However, T4, the most aggressive cell line, even exhibited a weakly significant increase in vimentin mRNA levels after SEMA3F treatment (Fig. 5 d).
← all excerpts
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma.
1
—
—